Fukuyama City Hospital
In research, Fukuyama City Hospital stands highest in Medicine (#9,638 of 10,443 worldwide) and Health Sciences (#11,379 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 8.8× its share of world research.
- World rank, 2022–2025
- #25,032 of 28,054 · #36,457 all time
- Rank in Japan
- #861 of 1,070
- Research works
- 564 ▲ 58% vs 2013–17
- Citations
- 3.1k 5.5 per fractional work
- Top-10% rate
- 4.0% record average 16.5%
- Open access
- 57% world 28%
What is Fukuyama City Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,638 of 10,443 | 4.0% | 109 | #14443 | |
| Health SciencesDomain | #11,379 of 11,982 | 3.9% | 113 | #16496 |
Each strip is that field’s whole ranked pool, with the notch where Fukuyama City Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Fukuyama City Hospital specialise in?
Where its research is concentrated relative to its size: Surgery takes 8.8× the share of its output that it takes of world research.
- SurgerySubfield · 26.5 works8.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
- Medicine 4.4×
- Veterinary 2.4×
- Immunology and Microbiology 2.3×
- Health Professions 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Nursing 0.6×
- Neuroscience 0.5×
- Psychology 0.3×
- Dentistry 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Mathematics 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Materials Science 0.1×
- Social Sciences 0.1×
- Chemistry 0.0×
- Computer Science 0.0×
- Engineering 0.0×
- Arts and Humanities 0.0×
- Physics and Astronomy 0.0×
- Agricultural and Biological Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Fukuyama City Hospital?
Ranked on the composite score, Ichiro Takata, Toru Ueki and Toshiyuki Komaki lead among researchers whose main affiliation is Fukuyama City Hospital.
- 1 Ichiro Takata Japan · #134,375 worldwide 418 citations · 20 works
- 2 Toru Ueki Japan · #591,776 worldwide 34 citations · 16 works
- 3 Toshiyuki Komaki Japan · #941,367 worldwide 11 citations · 17 works
- 4 Hiroaki Sakai Japan · #1,074,129 worldwide 46 citations · 35 works
- 5 Toshifumi Tsuji Japan · #1,183,186 worldwide 7 citations · 15 works
- 6 Naohiro Oda Japan · #1,284,594 worldwide 15 citations · 18 works
- 7 Keizo Kagawa Japan · #1,392,061 worldwide 9 citations · 27 works
- 8 Kohei Oka Japan · #1,463,115 worldwide 8 citations · 20 works
- 9 Yukio Kioka Japan · #1,485,186 worldwide 4 citations · 17 works
- 10 Atsushi Kawashima Japan · #1,493,672 worldwide 10 citations · 19 works
Which keywords describe research at Fukuyama City Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Immunotherapy, Surgical Management, Prognostic Factors, Clinical Practice Guidelines, Treatment and Diagnosis.
- PET Imaging
- Liver Cancer
- Targeted Therapy
- Hepatocellular Carcinoma
- Clinical Guidelines
- Gemcitabine
- Gastric Cancer
- Pancreatic Cancer
- Meta-Analysis
- Endoscopic Resection
- Metastasis
- Cholangiocarcinoma
- Radiotherapy
- Risk Factors
- Neoadjuvant Therapy
- Inflammation
- Diagnosis
- Prognostic Factors
- Treatment
- Chemotherapy
- Epidemiology
- Immunotherapy
- Surgical Management
- Clinical Practice Guidelines
- Management
- Tumor Microenvironment
- Quality of Life
- Complications
- Molecular Characterization
- Surgery
- Survival Analysis
- Genetic Mutations
- Molecular Profiling
- Adjuvant Therapy
- Palliative Treatment
- Surgical Complications
- Radiofrequency Ablation
- Survival
- Nutritional Support
- Sorafenib
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 3.8×63 topics
- Chemotherapy10▲ 12×19 topics
- Immunotherapy9▲ 10×16 topics
- Treatment9▲ 5.9×26 topics
- Surgical Management8▲ 16×14 topics
- Prognostic Factors8▲ 15×14 topics
- Clinical Practice Guidelines8▲ 12×12 topics
- Diagnosis8▲ 6.6×23 topics
- Management7▲ 7.0×20 topics
- Inflammation7▲ 2.5×28 topics
- Tumor Microenvironment6▲ 10×8 topics
- Neoadjuvant Therapy5▲ 16×5 topics
- Quality of Life4▲ 2.3×17 topics
- Risk Factors4▲ 2.9×18 topics
- Complications4▲ 5.8×11 topics
- Radiotherapy4▲ 7.5×11 topics
- Molecular Characterization4▲ 16×5 topics
- Cholangiocarcinoma4▲ 35×2 topics
- Surgery4▲ 7.8×8 topics
- Metastasis3▲ 7.8×6 topics
- Survival Analysis3▲ 9.8×5 topics
- Endoscopic Resection3▲ 26×2 topics
- Genetic Mutations3▲ 5.8×12 topics
- Meta-Analysis3▲ 4.0×6 topics
- Molecular Profiling3▲ 23×3 topics
- Pancreatic Cancer3▲ 21×2 topics
- Adjuvant Therapy3▲ 18×2 topics
- Gastric Cancer3▲ 20×3 topics
- Palliative Treatment3▲ 35×2 topics
- Gemcitabine3▲ 30×1 topic
- Surgical Complications3▲ 27×1 topic
- Clinical Guidelines3▲ 7.1×6 topics
- Radiofrequency Ablation3▲ 19×2 topics
- Hepatocellular Carcinoma2▲ 9.5×3 topics
- Survival2▲ 15×3 topics
- Targeted Therapy2▲ 8.7×4 topics
- Nutritional Support2▲ 20×2 topics
- Liver Cancer2▲ 33×1 topic
- Sorafenib2▲ 33×1 topic
- PET Imaging2▲ 10×4 topics
Which research topics does Fukuyama City Hospital publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis, Esophageal and GI Pathology and Pancreatitis Pathology and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 2 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
- 3 Esophageal and GI Pathology Surgery 2 works
- 4 Pancreatitis Pathology and Treatment Surgery 2 works
- 5 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 2 works
- 6 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 2 works
- 7 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 2 works
- 8 Tracheal and airway disorders Pulmonary and Respiratory Medicine 2 works
- 9 Trauma Management and Diagnosis Surgery 2 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fukuyama City Hospital's research output changed?
Output in 2018–2022 was 58% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Fukuyama
- Fukuyama University
- Fukuyama Cardiovascular Hospital
- Chugoku Central Hospital
- Fukuyama City University
- Kobatake Hospital
- Fukuyama Heisei University
- Fukuyama City Zoo
- Hiroshima Prefectural Museum of History
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.